Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 1Recurrence 1Neoplasms 1Carcinoma in Situ 1

Interventions

Vinorelbine 4Dexamethasone 4Filgrastim 3Vincristine 2Peripheral Blood Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Fenretinide 2Etoposide 2Cytarabine 2Carmustine 2Bortezomib 2zanubrutinib 1relatlimab 1pomalidomide 1pegaspargase 1palbociclib 1liposomal amphotericin B 1ixazomib 1irinotecan sucrosofate 1interferon gamma-1b 1interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1imetelstat 1etoposide phosphate 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carfilzomib 1auricularum 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Recurrence × Nicotine Replacement Therapy × Clear all
NCT03808818 2025-03-18

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

Eastern Cooperative Oncology Group

Phase NA Completed
306 enrolled 20 charts

Carcinoma in Situ, Neoplasms, Recurrence, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡